In addition, we established that RGE effectively reduced hPD-L1 MC38 tumor growth via inducing the CD8+ T cell infiltration and GrB release in the tumor microenvironment in allograft tumor humanized PD-1/PD-L1 knock-in mouse models. This evidence concerns the gene CD8A and neoplasm.